Dr. Mixson is a Scientific Founder of Sirnaomics and Professor at the University of Maryland. He is an expert in cancer, polymer design and drug delivery. He spearheaded the HK (histidine-lysine) polymer nanoparticle technology for siRNA delivery in vitro and in vivo which is now demonstrating tremendous potential in delivery of RNAi therapeutics. Dr. Mixson’s laboratory is developing novel gene targeting approaches for treating cancer. He received his B.A. from Vanderbilt University, and his M.D. degree from Emory University.